• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Coral
    |
    Weekly News Recap #Phispers

    J&J to spin off consumer biz within two years; Biden nominates Califf as FDA chief

    After a gap of a week, Phispers is back with reports of some big developments in the world of pharmaceuticals. The biggest news...

    Impressions : 1853

    BMS buys biopharma firm MyoKardia for US$ 13.1 billion; Concerns emerge over quality of acetazolamide

    This week, Phispers has more updates on Covid-19 vaccines and therapies. In the US, President Donald Trump contracted the vir...

    Impressions : 88812

    Mylan’s valsartan facility gets FDA warning letter; US sues Gilead over HIV drug patents

    This week, Phispers has news on Mylan’s valsartan facility in India receiving an FDA warning letter for nitrosamine conta...

    Impressions : 4478

    US Senator seeks “unannounced” FDA inspections; Nektar reports manufacturing issues with lead project

    This week in Phispers, we bring you news about Nektar Therapeutics which disclosed declining efficacy of its lead project due t...

    Impressions : 2685

    Apotex explores sale; Perrigo looks at selling prescription business; Takeda puts Latam biz on the block

    This week, Phispers has good news for patients on sartan drugs. For the first time since nitrosamine impurities were discovere...

    Impressions : 7460

    Astra strikes US$ 6.9 billion oncology deal with Daiichi; Cipla, Jubilant, Indoco’s FDA inspection updates

    This week, Phispers brings you news about AstraZeneca’s US$ 6.9 billion deal with Japanese drug major Daiichi Sankyo, whe...

    Impressions : 2720

    Sanofi and AbbVie CEOs suffer pay cuts, FDA Warning Letters to Pfizer, Jubilant’s Indian operations

    This week, Phispers brings you news about two antidepressants — J&J’s esketamine and Allergan’s rapastine...

    Impressions : 3604

    FDA proposes limits on ‘sartan’ nitrosamine impurities; Text messages add new twist to US generic price fixing litigation

    In our final Phispers of 2018, we bring you news on how the big pharmaceutical companies in the US plan to ring in the new year...

    Impressions : 5088

    Bayer to cut 12,000 jobs; GSK buys cancer drugmaker Tesaro for US$ 5 billion

    This week, Phispers has news on German drug major Bayer, which has drawn out a revamp plan that includes plans to slash 12,000 ...

    Impressions : 2811

    FDA approves first flu drug in 20 years; Trump proposes global index to check drug price rise

    This week, Phispers brings you news on US President Donald Trump’s new payment model, proposed ahead of the midterm polls...

    Impressions : 6507

    Aurobindo’s sartan banned in Europe; Dr. Reddy’s cost optimization drive continues, sells off another site

    This week, Phispers brings you news from Dr. Reddy’s Laboratories in India which is divesting its API plant in Hyderabad ...

    Impressions : 3870

    New Twists to Sartans Impurities Saga; Fish Oil Drug Makes Heart Medicine History

    This week, Phispers brings you new twists to the valsartan impurities saga. First, the FDA posted its observations at Zhejiang...

    Impressions : 3645

    Novartis seeks to clean image, links employee bonuses to ethics; EMA, FDA probe new impurity in valsartan

    This week, Phispers brings you the latest on the valsartan contamination. FDA and EMA have found the presence of an additional ...

    Impressions : 2758

    FDA, EMA highlight more concerns over APIs from China; FDA slams Apotex’s India operations

    This week, Phispers brings you more news on quality problems with active pharmaceutical ingredients from China. The FDA commiss...

    Impressions : 4970

    Headwinds at Mylan; Chinese API Adulteration Concerns Trigger Another US Drug Recall

    This week in Phispers, we look at Mylan’s US operations that declined 22 percent due to lower volumes. Moreover, quality ...

    Impressions : 6930

    High-level exit at Dr. Reddy’s; Drug stockpiling starts as firms face ‘no-deal Brexit’ blues

    With Britain preparing for a ‘no-deal Brexit’, Phispers this week looks at how pharmaceutical companies are ex...

    Impressions : 3394

    Pfizer halts manufacturing post FDA inspection in India; Aurobindo buys Apotex’s European operations in 5 countries

    This week, Phispers brings you news on US FDA’s new task force that will look for solutions to perpetual drug shortages. ...

    Impressions : 5017

    Pfizer rejigs into three businesses; Cancer causing impurity in China-made API leads to major EU drug recall

    This week in Phispers, we bring you news on Pfizer reorganizing itself into three businesses — Innovative Medicines, Esta...

    Impressions : 4811

    Novartis buys gene therapy for US$ 8.7 billion; France to target healthcare for its AI strategy

    This week in Phispers, we have some good and bad news on Swiss drugmaker, Novartis. While it acquired gene-therapy company AveX...

    Impressions : 4375

    China sees sharp rise in U.S. generic approvals; GSK opts out of Pfizer’s OTC business race

    This week, Phispers brings you news on Pfizer’s OTC auction. After Reckitt Benckiser, even GSK opted out of the race, le...

    Impressions : 3734

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.